> A University of Nebraska Medical Center researcher has received a 5-year, $3.3 million grant from NIH to study 10 rare diseases that affect children beginning in infancy or early childhood and throughout their life. Release
> Amgen ($AMGN) is looking into ways to ramp up production of ZMapp, an investigational drug developed by San Diego-based Mapp Biopharmaceutical to fight Ebola. More
> Immunovaccine unveiled positive results from a preclinical study, showing that its DepoVax delivery system prevented anthrax infections in monkeys exposed to the bacteria. Release
> Tekmira Pharmaceuticals ($TKMR) rolled out new preclinical data, showing that its RNA interference therapy TKM-HBV was effective in mice against hepatitis B. More